REPORTS

Let’s Pullulate and Expand Your Business

Global Glucagon Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Aug 13, 2020  |  135 PAGES  |  REPORT CODE: CMM379312
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

The global glucagon market report focuses on the global, regional and company-level glucagon sales and value. The report represents the overall market size of glucagon by analyzing historical data and future prospects. This report focuses on several key regions: North America, Europe, China and Japan. The report also calculated market size, glucagon sales, prices, revenue, gross margin and market share, cost structure and growth rate. The Glucagon market report provides comprehensive insights on the latest industry trends, market forecasts and growth drivers.

The increasing prevalence and incidence of hypoglycemia, coupled with the continuous innovation of emergency glucagon, are the main factors driving the growth of the global market. Increasing funding for healthcare infrastructure is driving the growth of the target market. The increasing number of heart-related problems among the elderly has indirectly promoted the growth of the global glucagon market, because glucagon is the guardian of the surge in catecholamines in the heart.

The Glucagon is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The research provides insights for the global Glucagon market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Glucagon industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Glucagon Market Segmentations:

By Players:

  • Novo Nordisk

  • Eli Lilly

  • Fresenius Kabi

  • Torrent Labs

  • Taj Pharmaceuticals

  • Xeris Pharmaceuticals

By Types:

  • Inject Glucagon

  • Nasal Glucagon

By End-User:

  • Emergency Kits

  • General Use

  • Diagnostic & Motility

  • Cardiogenic Shock

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top